Showing 15 posts of 1050 posts found.

BMS breast cancer drug rejected

November 27, 2008
Sales and Marketing BMS, Cancer, breast cancer

Bristol-Myers Squibb's breast cancer drug Ixempra has suffered a setback in the EU over safety concerns.The Committee for Medicinal Products …

Boehringer’s cancer drug enters phase III

November 21, 2008
Sales and Marketing Boehringer, Cancer

Boehringer Ingelheim's new lung cancer drug Vargatef has entered phase III trials.The drug is part of the manufacturer's burgeoning oncology …

Lilly eyes oncology focus with ImClone acquisition

October 9, 2008
Sales and Marketing Cancer, MA, lilly

Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …

Gardasil and Cervarix share innovation prize

September 25, 2008
Sales and Marketing Cancer, Gardasil, prix galien, vaccines

Rival vaccine products that will prevent thousands of women developing cervical cancer have been declared joint winners of the prestigious …

Brown to scrap prescription costs for cancer patients

September 24, 2008
Cancer, NHS

Patients suffering from cancer won't have to pay for prescriptions after April next year under new government plans. Prime minister …

GSK seeks risk-sharing deal for Tyverb

September 17, 2008
Sales and Marketing Cancer, GSK, NICE, par

GlaxoSmithKline has approached the government for a new pricing deal on its breast cancer drug Tyverb, which could make it …


GSK unveils new cancer unit

September 17, 2008
Research and Development Cancer, GSK

 GSK has unveiled a new integrated oncology R&D unit aimed at enhancing its presence in cancer care.The unit will be …

Patient wins legal battle for Revlimid

September 12, 2008
Sales and Marketing Cancer, Revlimid

A cancer patient has won access to cancer drug Revlimid in a court battle with his local PCT. West Sussex …

Government looks set to allow top-up fees

September 10, 2008
Sales and Marketing Cancer, Karol Sikora, NICE

 Patients in the UK could soon gain official clearance to pay ‘top up’ fees in order to receive the cancer …

European research centres unite to battle cancer

September 9, 2008
Research and Development Cancer, EU, France, Netherlands, Sweden

Top oncology specialists across Holland, France and Sweden have formed a new alliance to improve cancer research and reduce treatment …

The Pharmafocus Interview: Martin Dawkins

September 4, 2008
Research and Development, Sales and Marketing Bayer, Cancer, NICE, Xarelto, healthcare

 Martin Dawkins is an Englishman born and bred, but has spent most of his career working abroad, including the US, …

A new kind of patient advocate

July 30, 2008
Sales and Marketing Cancer, campaigner, market access, patient

When I came to interview Kate Spall, it was she, not I, who fired the first few questions. Her approach …

Erbitux set for first line treatment of colorectal cancer

June 5, 2008
Sales and Marketing Cancer, Merck Serono

Merck Serono's Erbitux looks set for approval in Europe as a first-line colon cancer treatment. Approved four years ago as …

Pfizer invests in oncology for future gains

May 16, 2008
Research and Development, Sales and Marketing Cancer, Pfizer

Pfizer has named Garry Nicholson as head of its new global oncology unit, a venture the company believes will bring …

Latest content